Natco Pharma launches Chlorantraniliprole under brand name NATGEN

TAGS

Natco Pharma Limited has launched Chlorantraniliprole (CTPR) 18.5% SC under the brand name NATGEN in the Indian market.

As per ‘s estimation, the present market size of Chlorantraniliprole containing products in will be more than INR 2,000 crores.

The -based pharma company had received approval from the Delhi High Court recently to manufacture Chlorantraniliprole and its formulations by using its own non-infringing process.

See also  Benvic Group acquires US-based specialty compounder Chemres

Chlorantraniliprole is formulated into broad-spectrum insecticides that have application across a wide range of crops for pest management.

CATEGORIES
TAGS
Share This